Insulet Corporation (PODD) financial statements and ratios from SEC XBRL: revenue $2.71B (TTM), net margin 9.1%, revenue growth 33.9% YoY, P/E 33.6. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $2.71B |
| Net Margin | 9.1% |
| Revenue Growth (YoY) | 33.9% |
| EPS Growth (YoY) | 160.0% |
| FCF Growth (YoY) | 73.8% |
| P/E Ratio | 33.6 |
| EV / EBITDA | 16.1 |
| Price / Book | 7.81 |
| Price / Sales | 3.51 |
| FCF Yield | 4.1% |
| DCF Value (model) | $168.07 |
| DCF Upside vs Price | 14.4% |
| Altman Z-Score | 5.63 (safe) |
| Piotroski F-Score | 6/9 |
| Sector P/E (Healthcare) | 21.6 |
PODD overview · PODD earnings · PODD KPIs · PODD investor relations · PODD ownership · PODD peers · PODD filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.